SCHEMBL1016737

SCHEMBL1016737

O=C(C=CCN1CCSCC1)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.81
FGFR1 P11362 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016735 1.00 EGFR (0.81) EGFRFGFR1
SCHEMBL1015986 0.96 EGFR (0.77) EGFRFGFR1
SCHEMBL1013905 0.94 EGFR (0.88) EGFRFGFR1
SCHEMBL938936 0.94 EGFR (0.88) EGFRFGFR1
SCHEMBL1013904 0.94 EGFR (0.88) EGFRFGFR1
SCHEMBL938937 0.94 EGFR (0.88) EGFRFGFR1
SCHEMBL1018190 0.93 EGFR (0.87) EGFRFGFR1
SCHEMBL1018188 0.93 EGFR (0.87) EGFRFGFR1
SCHEMBL1017344 0.92 EGFR (0.85) EGFR
SCHEMBL939001 0.92 EGFR (0.85) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed